Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      BioNTech Highlights Late-Stage Lung Cancer Pipeline Momentum and First Global Data for Pumitamig/Elfetabart Drozuntecan Novel-Novel Combination at WCLC 2026
      Biotech

      BioNTech Highlights Late-Stage Lung Cancer Pipeline Momentum and First Global Data for Pumitamig/Elfetabart Drozuntecan Novel-Novel Combination at WCLC 2026

      August 20, 2026
      Edesa Biotech Announces Pricing of $25.0 Million Public Offering
      Biotech

      Edesa Biotech Announces Pricing of $25.0 Million Public Offering

      August 19, 2026
      IDEAYA Biosciences Announces Clinical Collaboration with Genentech in MTAP-Deleted KRAS G12D-Mutant Pancreatic Cancer
      Biotech

      IDEAYA Biosciences Announces Clinical Collaboration with Genentech in MTAP-Deleted KRAS G12D-Mutant Pancreatic Cancer

      August 19, 2026
      Rakovina Therapeutics Announces Results from 2026 Annual General Meeting
      Biotech

      Rakovina Therapeutics Announces Results from 2026 Annual General Meeting

      August 19, 2026
      Invitation to presentation of BioArctic’s second quarter report for April – June 2026 on August 26 at 9:30 a.m. CEST
      Biotech

      Invitation to presentation of BioArctic’s second quarter report for April – June 2026 on August 26 at 9:30 a.m. CEST

      August 19, 2026
      Hansa Biopharma announces first commercial kidney transplant patient treated with Idefirix in Australia
      Biotech

      Hansa Biopharma announces first commercial kidney transplant patient treated with Idefirix in Australia

      August 17, 2026
      Mesoblast Achieves Major Milestone Completing Patient Treatment in Pivotal Phase 3 Trial for Chronic Low Back Pain
      Biotech

      Mesoblast Achieves Major Milestone Completing Patient Treatment in Pivotal Phase 3 Trial for Chronic Low Back Pain

      August 16, 2026
      argenx Announces Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis
      Biotech

      argenx Announces Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis

      August 16, 2026
      Cognizant and Benchling Selected as Partners to Accelerate Kyowa Kirin’s R&D
      Biotech

      Cognizant and Benchling Selected as Partners to Accelerate Kyowa Kirin’s R&D

      August 16, 2026
      Avicanna Reports Q2 2026 Financial Results
      Biotech

      Avicanna Reports Q2 2026 Financial Results

      August 14, 2026
      « 1 2 3 4 5 … 155 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026